Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: United States Clear all

404 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200117
200211
200314
200417
200511
200626
200718
200817
200916
201010
201112
201210
201311
201418
20156
20168
201713
201813
201913
20206
202120
202216
202318
20248
202517
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed238
Active, not recruiting65
Recruiting42
Terminated42
Unknown status8
Withdrawn4
Suspended2
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology33
Hoffmann-La Roche24
AstraZeneca23
Novartis Pharmaceuticals21
National Cancer Institute (NCI)19
NSABP Foundation Inc16
Pfizer15
Eli Lilly and Company13
M.D. Anderson Cancer Center12
SWOG Cancer Research Network12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms404
Neoplasm Metastasis38
Neoplasms23
Breast Neoplasms, Male14
Triple Negative Breast Neoplasms11
Breast Diseases10
Carcinoma, Intraductal, Noninfiltrating10
Carcinoma, Ovarian Epithelial10
Hot Flashes10
Lung Neoplasms10

Trials

Showing 1 to 25 of 404. Each trial links to its page on Pharma Observatory.

304 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.